Table 1 Description and distribution of condensed staging
Stage | T status | N status | M status | Cancer site | Re-settlers N (%) | General population N (%) |
|---|---|---|---|---|---|---|
Local | Any | – | – | Lung cancer | 5 (5.3%) | 1221 (7.8%) |
Colorectal cancer | 9 (11.5%) | 3059 (16.1%) | ||||
Breast cancer | 31 (33.7%) | 5512 (35.0%) | ||||
Prostate cancer | 4 (7.5%) | 1357 (11.0%) | ||||
Malignant melanoma | 12 (57.1%) | 1514 (53.9%) | ||||
Stomach cancer | 11 (16.9%) | 367 (7.5%) | ||||
All sites combined | 72 (17.9%) | 13,030 (18.5%) | ||||
Any | – | Missing | Lung cancer | 1 (1.1%) | 436 (2.8%) | |
Colorectal cancer | 17 (21.8%) | 3505 (18.5%) | ||||
Breast cancer | 4 (4.3%) | 883 (5.6%) | ||||
Prostate cancer | 14 (26.4%) | 2069 (16.7%) | ||||
Malignant melanoma | 1 (4.8%) | 39 (1.4%) | ||||
Stomach cancer | 3 (4.6%) | 358 (7.3%) | ||||
All sites combined | 40 (9.9%) | 7290 (10.4%) | ||||
Advanced | Any | + | – | Lung cancer | 22 (23.4%) | 2272 (14.6%) |
Colorectal cancer | 9 (11.5%) | 1862 (9.8%) | ||||
Breast cancer | 30 (32.6%) | 3579 (22.7%) | ||||
Prostate cancer | 0 (0.0%) | 110 (0.9%) | ||||
Malignant melanoma | 1 (4.8%) | 107 (3.8%) | ||||
Stomach cancer | 8 (12.3%) | 462 (9.4%) | ||||
All sites combined | 70 (17.4%) | 8392 (11.9%) | ||||
Any | + | Missing | Lung cancer | 7 (7.4%) | 715 (4.6%) | |
Colorectal cancer | 15 (19.2%) | 2555 (13.5%) | ||||
Breast cancer | 9 (9.8%) | 1352 (8.6%) | ||||
Prostate cancer | 0 (0.0%) | 261 (21.1%) | ||||
Malignant melanoma | 0 (0.0%) | 29 (1.0%) | ||||
Stomach cancer | 7 (10.8%) | 622 (12.6%) | ||||
All sites combined | 38 (9.4%) | 5534 (7.9%) | ||||
Any | Any | + | Lung cancer | 33 (35.1%) | 5393 (34.6%) | |
Colorectal cancer | 15 (19.2%) | 2861 (15.1%) | ||||
Breast cancer | 8 (8.7%) | 1115 (7.1%) | ||||
Prostate cancer | 1 (1.9%) | 605 (4.9%) | ||||
Malignant melanoma | 2 (9.5%) | 156 (5.6%) | ||||
Stomach cancer | 14 (21.5%) | 988 (20.1%) | ||||
All sites combined | 73 (18.1%) | 11,118 (15.8%) | ||||
Missing | Any | Missing | – | Lung cancer | 1 (1.1%) | 322 (2.1%) |
Colorectal cancer | 0 (0.0%) | 226 (1.2%) | ||||
Breast cancer | 0 (0.0%) | 312 (2.0%) | ||||
Prostate cancer | 0 (0.0%) | 572 (4.6%) | ||||
Malignant melanoma | 2 (9.5%) | 134 (4.8%) | ||||
Stomach cancer | 0 (0.0%) | 60 (1.2%) | ||||
All sites combined | 3 (0.7%) | 1626 (2.3%) | ||||
Any | Missing | Missing | Lung cancer | 25 (26.6%) | 5206 (33.4%) | |
Colorectal cancer | 13 (16.7%) | 4879 (25.8%) | ||||
Breast cancer | 10 (10.9%) | 2989 (19.0%) | ||||
Prostate cancer | 34 (64.2%) | 7400 (59.8%) | ||||
Malignant melanoma | 3 (14.3%) | 830 (29.5%) | ||||
Stomach cancer | 22 (33.8%) | 2063 (41.9%) | ||||
All sites combined | 107 (26.6%) | 23,367 (33.2%) |